IKT INHIBIKASE THERAPEUTICS INC Delisting Actions 8-K Filing 2023 - Delisting Inhibikase Therapeutics, Inc. received notice from Nasdaq that it has an additional 180-day period to regain compliance with the minimum bid price requirement for continued inclusion on The Nasdaq Capital Market.Get access to all SEC 8-K filings of the INHIBIKASE THERAPEUTICS INC